COPENHAGEN, Denmark ― Adding a novel anti–nerve growth factor product to opioids for terminally ill patients with inadequately controlled cancer pain did not significantly improve average cancer pain ...
Before chronic pain research had a name for its nemesis, Dr. Levi-Montalcini discovered the molecule that would revolutionize its treatment: Nerve Growth Factor. Exiled, underestimated, and elegant to ...
News-Medical.Net on MSN
Neural pain pathways found to play crucial role in bone fracture healing
When a house catches on fire, we assume that a smoke alarm inside will serve one purpose and one purpose only: warn the occupants of danger. But imagine if the device could transform into something ...
Researchers from Chiesi Farmaceutici SpA published new clinical data for CHF-6467, a recombinant modified form of human nerve growth factor (NGF), being evaluated for the treatment of neonatal hypoxic ...
Nerve growth factor receptor TrkA (in green) and co-receptor NRP1 (in purple) are coexpressed in the same nerve cells in mice. Researchers at the NYU Pain Research Center have found a new receptor for ...
Chronic pain affects about 20% of the population worldwide. It is – inadequately – treated with nonsteroidal anti-inflammatory compounds and opioids that lack efficacy and that are associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback